Yes, nanotechnology can significantly enhance the efficacy of cancer treatments. By delivering drugs directly to cancer cells, nanocarriers improve the bioavailability and concentration of therapeutic agents at the tumor site. This targeted delivery reduces side effects and enhances the therapeutic outcome. Additionally, theranostic nanoparticles combine therapeutic and diagnostic functions, allowing for real-time monitoring of treatment efficacy.
